Sphingolipid metabolism in systemic inflammation

Intensive Care Medicine: Annual Update 2007

Volumn , Issue , 2007, Pages 249-266

  Deigner, H P ^a   Gulbins, E ^b   Claus, R A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891986753     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-49518-7_23     Document Type: Chapter

References (83)

1. Chalfant CE, Spiegel S (2005) Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci 118:4605-4612
2. Baumruker T, Prieschl EE (2002) Sphingolipids and the regulation of the immune response. Semin Immunol 14:57-63
3. Pettus BJ, Chalfant CE, Hannun YA (2004) Sphingolipids in inflammation: roles and implications. Curr Mol Med 4:405-418
4. Hinkovska-Galcheva V, Boxer LA, Kindzelskii A, et al (2005) Ceramide 1-phosphate, a mediator of phagocytosis. J Biol Chem 280:26612-26621
5. Gomez-Munoz A, Kong JY, Salh B, Steinbrecher UP (2004) Ceramide-1-phosphate blocks apo-ptosis through inhibition of acid sphingomyelinase in macrophages. J Lipid Res 45:99-105
6. van Meer G, Lisman Q (2002) Sphingolipid transport: rafts and translocators. J Biol Chem 277:25855-25858
7. Birbes H, Luberto C, Hsu YT, El Bawab S, Hannun YA, Obeid LM (2005) A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria. Biochem J 386:445-451
8. Paris F, Grassme H, Cremesti A, et al (2001) Natural ceramide reverses Fas resistance of acid sphingomyelinase^/-) hepatocytes. J Biol Chem 276:8297-8305
9. Heinrich M, Wickel M, Winoto-Morbach S, et al (2000) Ceramide as an activator lipid of cathepsin D. Adv Exp Med Biol 477:305-315
10. Alessenko A, Chatterjee S (1995) Neutral sphingomyelinase: localization in rat liver nuclei and involvement in regeneration/proliferation. Mol Cell Biochem 143:169-174
11. Gulbins E, Li PL (2006) Physiological and pathophysiological aspects of ceramide. Am J Physiol Regul Integr Comp Physiol 290:Rll-26
12. Goni FM, Alonso A (2002) Sphingomyelinases: enzymology and membrane activity. FEBS Lett 531:38-46
13. Marchesini N, Hannun YA (2004) Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem Cell Biol 82:27-44
14. Schneider PB, Kennedy EP (1967) Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. J Lipid Res 8:202-209
15. Tomiuk S, Zumbansen M, Stoffel W (2000) Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase. J Biol Chem 275:5710-5717
16. Czarny M, Liu J, Oh P, Schnitzer JE (2003) Transient mechanoactivation of neutral sphingomyelinase in caveolae to generate ceramide. J Biol Chem 278:4424-4430
17. Hofmann K, Tomiuk S, Wolff G, Stoffel W (2000) Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase. Proc Natl Acad Sci USA 97:5895-5900
18. Adam-Klages S, Schwandner R, Adam D, Kreder D, Bernardo K, Kronke M (1998) Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor. J Leukoc Biol 63:678-682
19. Veldman RJ, Maestre N, Aduib OM, Medin JA, Salvayre R, Levade T (2001) A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. Biochem J 355:859-868
20. Levy M, Castillo SS, Goldkorn T (2006) nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis. Biochem Biophys Res Commun 344:900-905
21. Tabas I (1999) Secretory sphingomyelinase. Chem Phys Lipids 102:123-130
22. Schissel SL, Keesler GA, Schuchman EH, Williams KJ, Tabas I (1998) The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J Biol Chem 273:18250-18259
23. Dhami R, Schuchman EH (2004) Mannose 6-phosphate receptor-mediated uptake is defective in acid sphingomyelinase-deficient macrophages: implications for Niemann-Pick disease enzyme replacement therapy. J Biol Chem 279:1526-1532
24. Ni X, Morales CR (2006) The lysosomal trafficking of acid sphingomyelinase is mediated by sortilin and mannose 6-phosphate receptor. Traffic 7:889-902
25. Marathe S, Schissel SL, Yellin MJ, et al (1998) Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J Biol Chem 273:4081-4088
26. Callahan JW, Jones CS, Davidson DJ, Shankaran P (1983) The active site of lysosomal sphingomyelinase: evidence for the involvement of hydrophobic and ionic groups. J Neurosci Res 10:151-163
27. Schissel SL, Jiang X, Tweedie-Hardman J, et al (1998) Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J Biol Chem 273:2738-2746
28. Niwa M, Kozawa O, Matsuno H, Kanamori Y, Hara A, Uematsu T (2000) Tumor necrosis factor-alpha-mediated signal transduction in human neutrophils: involvement of sphingomyelin metabolites in the priming effect of TNF-alpha on the fMLP-stimulated superoxide production. Life Sci 66:245-256
29. MacKinnon AC, Buckley A, Chilvers ER, Rossi AG, Haslett C, Sethi T (2002) Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. J Immunol 169:6394-6400
30. Prieschl EE, Csonga R, Novotny V, Kikuchi GE, Baumruker T (1999) The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc epsilon receptor I triggering. J Exp Med 190:1-8
31. Alemany R, Meyer zu Heringdorf D, van Koppen CJ, Jakobs KH (1999) Formyl peptide receptor signaling in HL-60 cells through sphingosine kinase. J Biol Chem 274: 3994-3999
32. Bollinger CR, Teichgraber V, Gulbins E (2005) Ceramide-enriched membrane domains. Bio-chim Biophys Acta 1746:284-294
33. Grassme H, Cremesti A, Kolesnick R, Gulbins E (2003) Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene 22:5457-5470
34. Gulbins E (2003) Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol Res 47:393-399
35. Gulbins E, Grassme H (2002) Ceramide and cell death receptor clustering. Biochim Biophys Acta 1585:139-145
36. Miyaji M, Jin ZX, Yamaoka S, et al (2005) Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis. J Exp Med 202: 249-59.
37. Gulbins E, Dreschers S, Wilker B, Grassme H (2004) Ceramide, membrane rafts and infections. J Mol Med 82:357-363
38. Gulbins E, Kolesnick R (2003) Raft ceramide in molecular medicine. Oncogene 22:7070-7077
39. Simons K, Ehehalt R (2002) Cholesterol, lipid rafts, and disease. J Clin Invest 110:597-603
40. Grassme H, Jendrossek V, Riehle A, et al (2003) Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 9:322-330
41. Ghosh S, Bhattacharyya S, Das S, et al (2001) Generation of ceramide in murine macrophages infected with Leishmania donovani alters macrophage signaling events and aids intracellular parasitic survival. Mol Cell Biochem 223:47-60
42. Grassme H, Riehle A, Wilker B, Gulbins E (2005) Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J Biol Chem 280:26256-26262
43. Josephs M, Katan M, Rodrigues-Lima F (2002) Irreversible inactivation of magnesium-dependent neutral sphingomyelinase 1 (NSM1) by peroxynitrite, a nitric oxide-derived oxidant. FEBS Lett 531:329-334
44. Won JS, Singh I (2006) Sphingolipid signaling and redox regulation. Free Radic Biol Med 40:1875-1888
45. Claus RA, Bunck AC, Bockmeyer CL, et al (2005) Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis. Faseb J 19:1719-1721
46. Qiu H, Edmunds T, Baker-Malcolm J, et al (2003) Activation of human acid sphingomyelinase through modification or deletion of C-terminal cysteine. J Biol Chem 278: 32744-32752
47. Zhang DX, Yi FX, Zou AP, Li PL (2002) Role of ceramide in TNF-alpha-induced impairment of endothelium-dependent vasorelaxation in coronary arteries. Am J Physiol Heart Circ Physiol 283:H1785-1794
48. Scheel-Toellner D, Wang K, Craddock R, et al (2004) Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood 104:2557-2564
49. Lightle S, Tosheva R, Lee A, et al (2003) Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine-palmitoyl transferase. Arch Bio-chem Biophys 419:120-128
50. Langmann T, Buechler C, Ries S, et al (1999) Transcription factors Spl and AP-2 mediate induction of acid sphingomyelinase during monocytic differentiation. J Lipid Res 40:870-880
51. Mathias S, Pena LA, Kolesnick RN (1998) Signal transduction of stress via ceramide. Biochem J 335:465-480
52. Drobnik W, Liebisch G, Audebert FX, et al (2003) Plasma ceramide and lysophosphatidylcho-line inversely correlate with mortality in sepsis patients. J Lipid Res 44:754-761
53. Delogu G, Famularo G, Amati F, et al (1999) Ceramide concentrations in septic patients: a possible marker of multiple organ dysfunction syndrome. Crit Care Med 27:2413-2417
54. Takahashi T, Abe T, Sato T, et al (2002) Elevated sphingomyelinase and hypercytokinemia in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 24:401-404
55. Kornhuber J, Medlin A, Bleich S, et al (2005) High activity of acid sphingomyelinase in major depression. J Neural Transm 112:1583-1590
56. Sathishkumar S, Boyanovsky B, Karakashian AA, et al (2005) Elevated sphingomyelinase activity and ceramide concentration in serum of patients undergoing high dose spatially fractionated radiation treatment: implications for endothelial apoptosis. Cancer Biol Ther 4:979-986
57. Goggel R, Winoto-Morbach S, Vielhaber G, et al (2004) PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. Nat Med 10:155-160
58. Zimmerman GA, Mclntyre TM, Prescott SM, Stafforini DM (2002) The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 30: S294-301
59. Garcia-Ruiz C, Colell A, Mari M, et al (2003) Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest 111:197-208
60. Llacuna L, Mari M, Garcia-Ruiz C, Fernandez-Checa JC, Morales A (2006) Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. Hepatology 44: 561-572
61. Romiti E, Vasta V, Meacci E, et al (2000) Characterization of sphingomyelinase activity released by thrombin-stimulated platelets. Mol Cell Biochem 205:75-81
62. Bhatia R, Matsushita K, Yamakuchi M, Morrell CN, Cao W, Lowenstein CJ (2004) Ceramide triggers Weibel-Palade body exocytosis. Circ Res 95:319-324
63. Loidl A, Sevcsik E, Riesenhuber G, Deigner HP, Hermetter A (2003) Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells. J Biol Chem 278:32921-32928
64. Loidl A, Claus R, Ingolic E, Deigner HP, Hermetter A (2004) Role of ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells. Biochim Biophys Acta 1690:150-158
65. Claus RA, Wustholz A, Muller S, et al (2005) Synthesis and antiapoptotic activity of a novel analogue of the neutral sphingomyelinase inhibitor scyphostatin. Chembiochem 6:726-737
66. Arenz C, Thutewohl M, Block O, Waldmann H, Altenbach HJ, Giannis A (2001) Manumycin A and its analogues are irreversible inhibitors of neutral sphingomyelinase. Chembiochem 2:141-143
67. Yokomatsu T, Takechi H, Akiyama T, et al (2001) Synthesis and evaluation of a difluorome-thylene analogue of sphingomyelin as an inhibitor of sphingomyelinase. Bioorg Med Chem Lett 11: 1277-12780
68. Kolzer M, Werth N, Sandhoff K (2004) Interactions of acid sphingomyelinase and lipid bilay-ers in the presence of the tricyclic antidepressant desipramine. FEBS Lett 559:96-98
69. Brinkmann V, Lynch KR (2002) FTY720: targeting G-protein-coupled receptors for sphingo-sine 1-phosphate in transplantation and autoimmunity. Curr Opin Immunol 14:569-575
70. Hassler DF, Laethem RM, Smith GK (2000) A high throughput sphingomyelinase assay. Methods Enzymol 311:176-184
71. Olivera A, Spiegel S (1998) Sphingosine kinase. Assay and product analysis. Methods Mol Biol 105:233-242
72. Bartelsen O, Lansmann S, Nettersheim M, Lemm T, Ferlinz K, Sandhoff K (1998) Expression of recombinant human acid sphingomyelinase in insect Sf21 cells: purification, processing and enzymatic characterization. J Biotechnol 63:29-40
73. He X, Chen F, Dagan A, Gatt S, Schuchman EH (2003) A fluorescence-based, high-performance liquid chromatographic assay to determine acid sphingomyelinase activity and diagnose types A and B Niemann-Pick disease. Anal Biochem 314:116-120
74. He X, Dagan A, Gatt S, Schuchman EH (2005) Simultaneous quantitative analysis of ceramide and sphingosine in mouse blood by naphthalene-2, 3-dicarboxyaldehyde derivatization after hydrolysis with ceramidase. Anal Biochem 340:113-122
75. Liu B, Hannun YA (2000) Sphingomyelinase assay using radiolabeled substrate. Methods Enzymol 311:164-167
76. Tomas M, Duran JM, Lazaro-Dieguez F, Babia T, Renau-Piqueras J, Egea G (2004) Fluorescent analogues of plasma membrane sphingolipids are sorted to different intracellular compartments in astrocytes; Harmful effects of chronic ethanol exposure on sphingolipid trafficking and metabolism. FEBS Lett 563:59-65
77. Pagano RE, Chen CS (1998) Use of BODIPY-labeled sphingolipids to study membrane traffic along the endocytic pathway. Ann N Y Acad Sci 845:152-160
78. Bielawski J, Szulc ZM, Hannun YA, Bielawska A (2006) Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 39:82-91
79. Merrill AH Jr, Sullards MC, Allegood JC, Kelly S, Wang E (2005) Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 36:207-224
80. Ogretmen B, Pettus BJ, Rossi MJ, et al (2002) Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. Role for endogenous ceramide in mediating the action of exogenous ceramide. J Biol Chem 277:12960-12969
81. Osawa Y, Uchinami H, Bielawski J, Schwabe RF, Hannun YA, Brenner DA (2005) Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha. J Biol Chem 280:27879-27887
82. Birbes H, El Bawab S, Hannun YA, Obeid LM (2001) Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. Faseb J 15: 2669-2679
83. Marchesini N, Luberto C, Hannun YA (2003) Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism. J Biol Chem 278:13775-13783